Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic ICD Sales Better Than Expected, But Some Share Goes To St. Jude

This article was originally published in The Gray Sheet

Executive Summary

Medtronic's sales of implantable cardioverter defibrillators beat analyst expectations in the most recent fiscal quarter despite lingering fall-out from the firm's October Fidelis ICD lead recall

You may also be interested in...



St. Jude Medical Gains Market Share, Increases Outlook On Strong ICD Sales

St. Jude Medical took another two to three points of global implantable cardioverter defibrillator market share in the first half of the year, on the back of 40 ICD and pacemaker product launches in the past two years, the company said July 16

St. Jude Medical Gains Market Share, Increases Outlook On Strong ICD Sales

St. Jude Medical took another two to three points of global implantable cardioverter defibrillator market share in the first half of the year, on the back of 40 ICD and pacemaker product launches in the past two years, the company said July 16

Endeavor Stent’s Debut Drives 22% Growth In Medtronic Cardiovascular Biz

Medtronic's Endeavor zotarolimus-eluting coronary stent captured over 20% of the U.S. drug-eluting stent market by the tail end of the firm's fiscal fourth quarter (ended April 25), the company reported May 20

Related Content

UsernamePublicRestriction

Register

MT025814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel